(Q40676597)

English

Pre-therapeutic dosimetry of normal organs and tissues of (177)Lu-PSMA-617 prostate-specific membrane antigen (PSMA) inhibitor in patients with castration-resistant prostate cancer

scientific article published on 31 July 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Pre-therapeutic dosimetry of normal organs and tissues of (177)Lu-PSMA-617 prostate-specific membrane antigen (PSMA) inhibitor in patients with castration-resistant prostate cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Levent Kabasakal

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26227531%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26227531%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26227531%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26227531%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

author name string

Mohammad AbuQbeitah

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26227531%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

Aslan Aygün

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26227531%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

Nami Yeyin

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26227531%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

publication date

31 July 2015

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

European Journal of Nuclear Medicine and Molecular Imaging

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26227531%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

42

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26227531%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26227531%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

1976-1983

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26227531%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

https://scigraph.springernature.com/pub.10.1007/s00259-015-3125-3

0 references

Expression of prostate-specific membrane antigen in normal, benign, and malignant prostate tissues

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3125-3

21 January 2018

Prostate-specific membrane antigen expression as a predictor of prostate cancer progression

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3125-3

21 January 2018

68Ga-complex lipophilicity and the targeting property of a urea-based PSMA inhibitor for PET imaging

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3125-3

21 January 2018

Preclinical evaluation of a bispecific low-molecular heterodimer targeting both PSMA and GRPR for improved PET imaging and therapy of prostate cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3125-3

21 January 2018

PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3125-3

21 January 2018

The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3125-3

21 January 2018

Evaluation of PSMA PET/CT imaging using a 68Ga-HBED-CC ligand in patients with prostate cancer and the value of early pelvic imaging.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3125-3

21 January 2018

[¹⁷⁷Lu]Lutetium-labelled PSMA ligand-induced remission in a patient with metastatic prostate cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3125-3

21 January 2018

Preclinical Evaluation of a Tailor-Made DOTA-Conjugated PSMA Inhibitor with Optimized Linker Moiety for Imaging and Endoradiotherapy of Prostate Cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3125-3

21 January 2018

Investigation of the relationship between linear attenuation coefficients and CT Hounsfield units using radionuclides for SPECT.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3125-3

21 January 2018

Patient dosimetry in radionuclide therapy: the whys and the wherefores

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3125-3

21 January 2018

Treatment planning in molecular radiotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3125-3

21 January 2018

Results of individual patient dosimetry in peptide receptor radionuclide therapy with 177Lu DOTA-TATE and 177Lu DOTA-NOC.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3125-3

21 January 2018

[177Lu-DOTAOTyr3]octreotate: comparison with [111In-DTPAo]octreotide in patients

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3125-3

21 January 2018

Bone marrow dosimetry in peptide receptor radionuclide therapy with [177Lu-DOTA(0),Tyr(3)]octreotate

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3125-3

21 January 2018

Renal function affects absorbed dose to the kidneys and haematological toxicity during ¹⁷⁷Lu-DOTATATE treatment

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3125-3

21 January 2018

Individualized dosimetry in patients undergoing therapy with (177)Lu-DOTA-D-Phe (1)-Tyr (3)-octreotate

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3125-3

21 January 2018

Peptide-receptor radionuclide therapy for endocrine tumors

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3125-3

21 January 2018

Individualized dosimetry of kidney and bone marrow in patients undergoing 177Lu-DOTA-octreotate treatment

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3125-3

21 January 2018

EANM Dosimetry Committee guidance document: good practice of clinical dosimetry reporting

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3125-3

21 January 2018

Radiotherapy dose-volume effects on salivary gland function

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3125-3

21 January 2018

Sensitivity of salivary glands to radiation: from animal models to therapies

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3125-3

21 January 2018

The impact of dose on parotid salivary recovery in head and neck cancer patients treated with radiation therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3125-3

21 January 2018

Salivary gland function 5 years after radioactive iodine ablation in patients with differentiated thyroid cancer: direct comparison of pre- and postablation scintigraphies and their relation to xerostomia symptoms

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3125-3

21 January 2018

Xerostomia. Part II: Relationship to nonoral symptoms, drugs, and diseases

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3125-3

21 January 2018

177Lu-[DOTA0,Tyr3] octreotate therapy in patients with disseminated neuroendocrine tumors: Analysis of dosimetry with impact on future therapeutic strategy.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3125-3

21 January 2018

EANM Dosimetry Committee guidelines for bone marrow and whole-body dosimetry

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3125-3

21 January 2018

Prostate-specific membrane antigen expression in normal and malignant human tissues

1 reference

https://pubmed.ncbi.nlm.nih.gov/26227531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salivary gland side effects commonly develop several weeks after initial radioactive iodine ablation

1 reference

https://pubmed.ncbi.nlm.nih.gov/26227531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Accuracy of the quantification of organ activity from planar gamma camera images

1 reference

https://pubmed.ncbi.nlm.nih.gov/26227531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MIRD pamphlet no. 16: Techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates

1 reference

https://pubmed.ncbi.nlm.nih.gov/26227531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone marrow dosimetry using blood-based models for radiolabeled antibody therapy: a multiinstitutional comparison.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26227531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differences in predicted and actually absorbed doses in peptide receptor radionuclide therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/26227531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40676597&oldid=1904476756"